CYTOFOTCPharmaceutical PreparationsFiscal year ends December 31
Altamira Therapeutics Ltd.
Financials through fiscal 2024, year ended Dec 31, 2024Last filing: 20-F on Apr 30, 2025
$0.09+0.00 (0.00%)
Close on Oct 19, 2026
Altamira Therapeutics statistics
Financials through Dec 31, 2024, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Altamira Therapeutics | Industry median |
|---|---|---|
| Market Cap | CHF 348.59K | CHF 62.39M |
| Enterprise Value | CHF 348.59K | CHF 27.59M |
Shares
| Measure | Altamira Therapeutics | Industry median |
|---|---|---|
| Shares Outstanding | 4,662,080 | 50,231,950 |
| Shares Change (YoY) | 980.2% | 10.4% |
| Float | 3,582,240 | 41,812,550 |
| Shares Held by Insiders | 23.2% | 19.3% |
Calculated by StockData from Altamira Therapeutics's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.